Week 5: Agents Used to Treat Acne Flashcards Preview

Simmons NURP 424 Advanced Pharmacology Across the Life Span > Week 5: Agents Used to Treat Acne > Flashcards

Flashcards in Week 5: Agents Used to Treat Acne Deck (36)
Loading flashcards...
1
Q

First-line therapy for acne vulgaris with closed comedones includes:

a) oral antibiotics
b) isotretinoin
c) benzoyl peroxide
d) hydrocortisone cream

A

C - Benzoyl peroxide - can be used as monotherapy

2
Q

Benzoyl peroxide mechanism of action

A
  • true comeolytic (mild) and antibacterial action
  • dekeratinizes the hair follicle and decreases the cohesion between the epithelial cells and follicular cells of the hair - when this happens the oil, WBC, bacteria, old skin cells can get out of the follicle
  • also kills bacteria
3
Q

Benzoyl peroxide ADRs

A
  • dryness, peeling, irritation
  • photosensitivity
  • can bleach clothes, sheets, towels
4
Q

Benzoyl peroxide Precautions/Contraindications

A
  • safe for use in pregnancy

- should not be applied at the same time as topical retinoids (apply this in the AM and retinoids in the PM)

5
Q

Erythromycin topical mechanism of action

A
  • topical antibiotic - a bacteriostatic macrolide antibiotic which binds to the P site of the 50S ribosomal subunit, interfering with protein synthesis
6
Q

Erythromycin topical Precautions/Contraindications

A
  • safe in pregnancy

- better tolerated than Clindamycin

7
Q

Clindamycin topical (topical antibiotic) ADR

A
  • burning and irritation

- diarrhea / colitis (rare)

8
Q

Azelaic acid (topical antibiotic) ADRs

A
  • skin hypopigmentation may occur - avoid in people with color
9
Q

Azelaic acid Precautions/Contraidictions

A
  • Pregnancy Category B
  • absorbed systemically even when applied in small amounts so may be excreted in breast milk - caution should be used in lactating women
10
Q

TRUE or FALSE

It is not appropriate to use Benzoyl Peroxide and either Clindamycin or Erythromycin on the same patient

A

FALSE - it is appropriate to be used on the same patient simultaneously - but the two products should be used at a different time of day (one medication in the morning and the other medication in the evening)

11
Q

Isotretinoin (Accutane) Mechanism of Action

A
  • systemic retinoid - prodrug of Retin-A
  • potent comeolytic
  • reduces sebum production
  • reduces sebaceous gland size
  • normalizes follicular keratinization
  • used for severe nodular cystic acne
12
Q

Isotretinoin (Accutane) Precautions/Contraindications

A
  • pregnancy category X - must verify the patient is not pregnant or trying to get pregnant before giving
  • should not be used in patients at risk for osteoporosis
13
Q

Isotretinoin (Accutane) ADRs

A
  • drying, peeling skin redness
  • photosensitivity
  • lethargy/fatigue
  • arthralgias/myalgias
  • mood changes - SI, mood swings, depression
14
Q

Tretinoin (Retin-A) [topical retinoid] - mechanism of action

A
  • potent comeolytic - de-keratinizes the hair follicle and decreases the cohesion between the epithelial cells and follicular cells of the hair
  • does not have antibiotic properties, but can enhance the penetration of other topical agents such as benzoyl peroxide
15
Q

When prescribing tretinoin (Retin-A), the nurse practitioner (NP) advises the patient to:

a) use it with benzoyl peroxide to minimize irritating effects
b) use a sunscreen because the drug is photosensitzing
c) add a sulfa-based cream to enhance anti-acne effects
d) expect a significant improvement in acne lesions after approximately 1 week of use

A

B - use a sunscreen because the drug is photosensitizing

- can also cause hypopigmentation

16
Q

Tretinoin (Retin-A) cautions

A
  • pregnancy category C -
  • thin layer is all that is needed
  • never use as monotherapy
17
Q

What are some important things to educate your patient on when using topical medications for acne?

A
  • Your acne may get worse before it gets better. Benefits may take 6-8 weeks to appear.
  • Use sunscreen.
  • Topical retinoids should not be used at the same time of day as topical antibiotics.
18
Q

All topical retinoids should be avoided in what patient conditions?

A
  • eczema, sunburn, or skin abrasions at the site of application
19
Q

You prescribe a topical medication and want it to have maximum absorption, so you choose the following vehicle:

a) gel
b) lotion
c) cream
d) ointment

A

D - ointments - more occlusive, so more potent

creams are less occlusive, so less potent and lotions are the lease potent

20
Q

You write a prescription for a topical agent and anticipate the greatest rate of absorption when it is applied to the:

a) palms of the hands
b) soles of the feet
c) face
d) abdomen

A

C - face

21
Q

One of the mechanisms of action of a topical corticosteroid preparation is as:

a) an antimitotic
b) an exfoliant
c) a vasoconstrictor
d) humectant

A

C - a vasoconstrictor

22
Q

To enhance the potency of a topical corticosteroid, the prescriber recommends that the patient apply the preparation:

a) to dry skin by gentle rubbing
b) and cover with an occlusive dressing
c) before bathing
d) with an emollient

A

B - and cover with an occlusive dressing

23
Q

Which of the following is the least potent topical corticosteroid?

a) betamethasone dipropionate 0.1% (Diprosone)
b) clobetasol propionate 0.05% (Cormax)
c) hydrocortisone 2.5%
d) fluocinonide 0.05% (Lidex)

A

C - hydrocortisone 2.5%

24
Q

Topical corticosteroid MOA & Classes

A
- anti-inflammatory, antipruritic, and vasoconstriction properties - used for dermatitis, psoriasis, eczema
Class I - very high strength
Class II and III - high strength
Class IV and V - intermediate strength
Class VI and VII - low strength
25
Q

Topical corticosteroid Cautions/Contraindications

A
  • do not use high-potency agents on face, palms, feet, groin, axilla
  • caution in pregnant patients; only use if benefits outweigh the risks
  • children are often more susceptible to the effects and require the lowest effective strength to be used
26
Q

Topical corticosteroid ADRs

A
  • local skin irritation - increase in the risk for secondary infections - tolerance may occur with prolonged used
  • adrenal function should be monitored - do not stop drug abruptly
27
Q

Topical calcineurin inhibitors “limus” (Pimecrolimus/Elidel and Tacrolimus/Protopic) Indications and MOA

A
  • atopic dermatitis/eczema
  • much more potent anti-immunologic and immunosuppressive - these are NOT STEROIDS
  • suppresses cellular immunity through inhibiting T-cell activation by binding to intracellular proteins, including calcineurin-dependent proteins. This results in inhibition of inflammatory cytokines and mediators from mast cells
28
Q

Topical calcineurin inhibitor cautions and contraindications

A
  • black box warning for long-term safety concern because of rare cases of malignancy - skin cancer
  • do not use occlusive dressing over this drug (do not use in the diaper area)
  • both should be avoided in children younger than two years and in immunosuppressed patients
29
Q

Situations when to use of topical calcineurin inhibitors

A
  • atopic dermatitis that is resistant to steroids - sensive areas like face, skin folds
    Elidel - approved for mild to moderate disease
    Protopic - approved for moderate to severe disease
30
Q

Topical calcineurin inhibitor ADRs

A
  • local reaction at site of application - burning, pruritus and tingling
  • H/A, fever, flu-like symptoms
31
Q

In the treatment of acne vulgaris, which lesions respond best to topical antibiotic therapy?

a) open comedones
b) cysts
c) inflammatory lesions
d) superficial lesions

A

C - inflammatory lesions

32
Q

You have initiated therapy for an 18-year-old man with acne vulgaris and have prescribed doxycycline. He returns in 3 weeks, complaining that his skin is “no better.” Your next action is to:

a) counsel him that 6 to 8 weeks of treatment is often needed before significant improvement is achieved
b) discontinue the doxycycline and initiate minocycline therapy
c) advise him that antibiotics are likely not an effective treatment for him and should not be continued
d) add a second antimicrobial agent such as trimethoprim-sulfamethoxazole

A

A - counsel him that 6 to 8 weeks of treatment is often needed before significant improvement is achieved

33
Q

Who is the best candidate for isotretinoin (Accutane) therapy?

a) a 17-year-old patient with pustular lesions and poor response to benzoyl peroxide
b) a 20-year-old patient with cystic lesions who has tried various therapies with minimal effect
c) a 14-year-old patient with open and closed comedones and family history of “ice pick” scars
d) an 18-year-old patient with inflammatory lesions and improvement with tretinoin (Retin-A)

A

B - a 20-year-old patient with cystic lesions who has tried various therapies with minimal effect

34
Q

In a 22-year-old woman using isotretinoin (Accutane) therapy, the NP ensures follow-up to monitor for all the following tests except:

a) hepatic enzymes
b) triglyceride measurements
c) pregnancy
d) platelet count

A

D - platelet count

35
Q

Leonard is an 18-year-old man who has been taking isotretinoin (Accutane) for the treatment of acne for the past 2 months. Which of the following is the most important question for the clinician to ask at his follow up office visit?

a) “Are you having any problems remembering to take your medication?”
b) “Have you noticed any dry skin around your mouth since you started using Accutane?”
c) “Do you notice any improvement in your skin?”
d) “Have you noticed any recent changes in your mood?”

A

D - “Have you noticed any recent changes in your mood?”

36
Q

In a 13-year-old female patient with mild acne and who experiences an inadequate response to benzoyl peroxide treatment, an appropriate treatment option would be to:

a) add a topical retinoid
b) add an oral antibiotic
c) consider isotretinoin
d) consider hormonal therapy

A

B - add an oral antibiotic

Decks in Simmons NURP 424 Advanced Pharmacology Across the Life Span Class (46):